Previous close | 1.9000 |
Open | 1.9300 |
Bid | 1.6900 x 1100 |
Ask | 1.9000 x 1800 |
Day's range | 1.8400 - 1.9500 |
52-week range | 1.6800 - 11.2400 |
Volume | |
Avg. volume | 555,096 |
Market cap | 93.853M |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.0970 |
Earnings date | 22 Feb 2022 - 28 Feb 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 31 Oct 2014 |
1y target est | 18.50 |
Participants on today's call are Evan Loh, M.D, chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer. Michael Bigham, executive chairman, and I will also be available for questions.
We feel now is a pretty good time to analyse Paratek Pharmaceuticals, Inc.'s ( NASDAQ:PRTK ) business as it appears the...
It is now my pleasure to introduce your host, Sarah Higgins, vice president of finance, controller, and principal accounting officer. Participants on today's call are Evan Loh, chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer.